Acute Coronary Syndrome

One MI survivor is raising awareness for heart attack symptoms in women after her Dec. 9 tweets about an unusual episode went viral.

Patients who present to the hospital with cardiogenic shock (CS) and are treated with an intra-aortic balloon pump (IABP) are more likely to survive if the device is implanted within an hour of CS onset, according to research published in the American Journal of Cardiology Dec. 4.

Individuals who live in greener neighborhoods might be less likely to develop heart disease and stroke than those residing in areas with fewer parks or green spaces, according to a Journal of the American Heart Association study published Dec. 5.

Results from a study published in the Journal of Women’s Health Nov. 27 suggest both miscarriages and a high number of births have a significant impact on women’s cardiovascular health, raising a mother’s risk for coronary heart disease (CHD), heart failure and even serious MI.

A man who says his nearly fatal myocardial infarction was triggered by January’s false missile alert in Hawaii is now suing the state and then-administrator of the Hawaii Emergency Management Agency for damages, CBS News reported.

People who are frail and older than 65 are at a 50 percent increased risk of major bleeding during hospitalizations for heart attack compared to nonfrail patients, according to research published Nov. 19 in JACC: Cardiovascular Interventions.

Major cardiology associations joined forces to update the 2012 universal definition of myocardial infarction and standardize what constitutes a heart attack.

A machine learning-based risk calculator developed to assess an individual’s long-term risk for atherosclerotic cardiovascular disease (ASCVD) identified 13 percent more high-risk patients and recommended unnecessary statin therapy 25 percent less often than standard risk assessment tools in initial tests, researchers reported in the Journal of the American Heart Association.

Results of the CIRT trial presented at the American Heart Association Scientific Sessions dimmed hopes that low-dose methotrexate can reduce cardiovascular events but furthered researchers’ understanding of which inflammation-targeting therapies might succeed in that regard.

Cancer is overtaking heart disease as the leading cause of death in the U.S., particularly in high-income counties, suggests a new analysis published in the Annals of Internal Medicine.

The Door-to-Unload pilot study concluded without any “prohibitive safety signals,” researchers reported at the American Heart Association 2018 Scientific Sessions, clearing the path for a larger trial to test the hypothesis that ventricular unloading prior to PCI with the Impella CP heart pump can reduce reperfusion injury.

VITAL and REDUCE-IT—both highly anticipated trials revolving around the cardiovascular benefits of fish oil products—delivered mixed results at this year’s AHA Scientific Sessions in Chicago, with one trial observing few heart benefits from omega-3s while the other saw a 25 percent reduction in major cardiovascular events with a purified eicosapentaenoic acid product.